Single-dose oral ivermectin in mild and moderate COVID-19 (RIVET-COV): A single-centre randomized, placebo-controlled trial.
. Curr Drug Abuse Rev. 2010 Jun;3(2):76-9. doi: 10.2174/1874473711003020076. Curr Drug Abuse Rev. 2010. PMID: 20712591 Review.
. Nat Med. 2021 Sep 7. doi: 10.1038/s41591-021-01490-8. Online ahead of print. Nat Med. 2021. PMID: 34493859
.
Item in Clipboard